T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$1.31B |
| 2 |
Home Depot
HD
|
+$1.07B |
| 3 |
Alibaba
BABA
|
+$1.06B |
| 4 |
Yum! Brands
YUM
|
+$887M |
| 5 |
Honeywell
HON
|
+$860M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
N
Netsuite Inc
N
|
+$1.59B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.33B |
| 3 |
Danaher
DHR
|
+$1.13B |
| 4 |
HBI
Hanesbrands
HBI
|
+$1.06B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$845M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.06% |
| 2 | Financials | 16.98% |
| 3 | Consumer Discretionary | 15.13% |
| 4 | Technology | 13.74% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Lennar Class A
LEN
$21B
| $140M | 0.03% |
3,431,549
-1,246
| -0% | -$50.4K |
|
502
Zimmer Biomet
ZBH
$19B
| $140M | 0.03% |
1,395,137
+945,460
| +210% | +$101M |
|
503
Sunstone Hotel Investors
SHO
$2.03B
| $139M | 0.03% |
9,127,958
+176,404
| +2% | +$2.46M |
|
504
TripAdvisor
TRIP
$1.29B
| $139M | 0.03% |
2,999,166
+33,089
| +1% | +$1.82M |
|
505
Bright Horizons
BFAM
$3.78B
| $139M | 0.03% |
1,986,081
+394,734
| +25% | +$26.9M |
|
|
RAI
506
DELISTED
Reynolds American Inc
RAI
| $139M | 0.03% |
2,481,425
+852,419
| +52% | +$45.2M |
|
507
Insmed
INSM
$27.3B
| $139M | 0.03% |
10,506,925
+469,053
| +5% | +$6.4M |
|
508
Glacier Bancorp
GBCI
$6.47B
| $138M | 0.03% |
3,815,017
-404,724
| -10% | -$13M |
|
509
Westamerica Bancorp
WABC
$1.4B
| $138M | 0.03% |
2,193,328
-392,250
| -15% | -$22.2M |
|
510
Ecolab
ECL
$77.2B
| $137M | 0.03% |
1,169,714
-129,772
| -10% | -$15.2M |
|
511
LCI Industries
LCII
$2.59B
| $137M | 0.03% |
1,271,876
+140,500
| +12% | +$14M |
|
512
Boston Beer
SAM
$1.89B
| $137M | 0.03% |
805,633
+310,238
| +63% | +$51.4M |
|
|
BNCL
513
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $137M | 0.03% |
7,423,435
-82,210
| -1% | -$1.34M |
|
514
TherapeuticsMD
TXMD
$24.1M
| $137M | 0.03% |
473,264
+3,955
| +0.8% | +$1.23M |
|
515
ManpowerGroup
MAN
$2.73B
| $136M | 0.03% |
1,531,280
-3,144,665
| -67% | -$259M |
|
516
Papa John's
PZZA
$804M
| $135M | 0.03% |
1,579,026
-255,375
| -14% | -$21.2M |
|
517
Brown & Brown
BRO
$23.8B
| $135M | 0.03% |
6,020,110
+316,538
| +6% | +$6.43M |
|
518
Cintas
CTAS
$80B
| $135M | 0.03% |
4,673,884
-1,216,932
| -21% | -$34.2M |
|
519
RE/MAX Holdings
RMAX
$274M
| $133M | 0.03% |
2,380,042
-39,630
| -2% | -$1.92M |
|
520
Halliburton
HAL
$28B
| $133M | 0.03% |
2,463,210
-790,826
| -24% | -$39.4M |
|
521
Hope Bancorp
HOPE
$1.85B
| $133M | 0.03% |
6,079,632
+1,973,880
| +48% | +$37.3M |
|
522
CNX Resources
CNX
$5.24B
| $133M | 0.03% |
8,727,850
-789,207
| -8% | -$12.5M |
|
523
Watsco Inc
WSO
$12.8B
| $131M | 0.03% |
885,283
+23,724
| +3% | +$3.44M |
|
|
SAGE
524
DELISTED
Sage Therapeutics
SAGE
| $131M | 0.03% |
2,558,333
+1,156,655
| +83% | +$54.5M |
|
525
Sherwin-Williams
SHW
$87.2B
| $130M | 0.03% |
1,455,303
-1,267,014
| -47% | -$112M |
|
Similar funds
T. Rowe Price Associates's Q4 2016 Portfolio in Review
As of Q4 2016, T. Rowe Price Associates held 2,620 positions worth $504B, up 1.2% from $498B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2016 filing shows 96 new, 950 increased, 1,023 reduced and 72 closed positions. Its largest new stake was Adient: 10,357,941 shares worth $607M. The largest sale was Netsuite Inc, an estimated $1.59B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2016 buy was Adient: 10,357,941 shares worth $607M.
- T. Rowe Price Associates added most to Wells Fargo in Q4 2016, an estimated $1.31B increase.
- T. Rowe Price Associates's biggest Q4 2016 reduction was NXP Semiconductors, cutting an estimated $1.33B.
- T. Rowe Price Associates fully exited Netsuite Inc in Q4 2016, selling an estimated $1.59B.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $504B portfolio in Q4 2016.
- T. Rowe Price Associates opened 96 new positions and closed 72 in Q4 2016.
- T. Rowe Price Associates's portfolio value rose 1.2% quarter-over-quarter to $504B.
Based on T. Rowe Price Associates's 13F filing for Q4 2016, filed 14 Feb 2017.